Clinical Evidence for Digital Health, AI & SaMD
Bioexcel supports manufacturers of software and AI-enabled medical technologies with clinical validation, dataset assessment, prospective and retrospective studies, statistical performance analysis, subgroup evaluation, human factors, post-market monitoring and regulatory clinical evidence.
Our approach connects algorithm performance to the real patient, intended user and clinical decision the software is designed to support.
Does Bioexcel Support AI Medical Device and SaMD Clinical Validation?
Yes. Bioexcel supports clinical validation of AI-enabled medical devices, SaMD and digital health technologies through study design, dataset assessment, retrospective or prospective validation, performance analysis, subgroup evaluation, human factors, biostatistics and post-market evidence.
Bioexcel Lifesciences & Research LLP supports clinical evidence programs for digital health, SaMD and AI-enabled medical devices, including study design, dataset feasibility, retrospective and prospective validation, subgroup analysis, biostatistics, human factors, PMCF, real-world evidence and clinical evaluation.
For our full software and AI/SaMD clinical validation service page, see Digital Health, SaMD & AI Clinical Validation. Pre-market pivotal or early-feasibility studies for AI-enabled devices are coordinated through our Clinical Investigation service.
Technologies We Can Support
Potential categories:
Diagnostic AI
Imaging AI
Predictive Algorithms
Clinical Decision Support
Remote Patient Monitoring
Digital Therapeutics
From Algorithm to Clinical Evidence
Intended Purpose
What clinical decision does the software support?
Target Population
Which patients should it work for?
User & Workflow
Who sees the output and what do they do with it?
Reference Standard
What defines the clinically correct answer?
Validation Data
Which independent clinical data will be used?
Performance
How accurately does the software perform?
Generalizability
Does it perform consistently across relevant subgroups and settings?
Clinical Utility
Does the output meaningfully support clinical care?
Lifecycle Evidence
How will performance be monitored after release?
Start With the Exact Clinical Role of the Software
- Does it diagnose?
- Does it classify?
- Does it predict?
- Does it quantify?
- Does it monitor?
- Does it recommend?
- Does it prioritize?
The Intended Purpose Should Specify
Without this, meaningful clinical validation is difficult.
Clinical Validation for AI-Assisted Diagnosis
Potential Performance Measures
Potential Evidence Sources
Can Bioexcel Validate Diagnostic AI?
Yes. Bioexcel can support diagnostic AI clinical validation using appropriate clinical datasets, reference standards, predefined performance metrics, subgroup analysis and statistical confidence intervals.
Evidence for Radiology and Medical Imaging Algorithms
Potential Applications
Potential Variables
Define the Clinical Truth Against Which AI Is Compared
The reference method should be independent from the AI result where possible.
Useful When Human Interpretation Is Part of the Comparison
- Does AI improve sensitivity?
- Does AI reduce reading time?
- Does AI change false-positive rate?
- Does AI improve consistency?
Should Account For
Validate Whether the Model Predicts Future Clinical Outcomes
Relevant Statistical Concepts
Predicted Risk Should Match Observed Risk
Potential Outputs
Can Bioexcel Assess Calibration of Predictive Medical AI?
Yes. Bioexcel can support calibration assessment for clinical prediction algorithms using appropriate statistical methods to compare predicted risk with observed outcomes.
Evaluate More Than Raw Algorithm Accuracy
- Does the clinician understand the recommendation?
- Does the recommendation influence management?
- Does it improve decision accuracy?
- Does it delay action?
- Does it create over-reliance?
- Can clinicians appropriately override it?
This connects algorithm validation with human factors.
Clinical Evidence for Connected Monitoring Technologies
Potential Products
- Measurement agreement
- Signal reliability
- Data completeness
- Alert accuracy
- Adherence
- User engagement
- Clinical response
When Digital Devices Measure a Physiological Parameter
Important
Correlation alone should not be treated as proof of agreement.
Existing Clinical Datasets Can Support AI Validation
Potential Sources
Assess
Can Bioexcel Conduct Retrospective AI Validation?
Yes. Bioexcel can support retrospective validation when the clinical dataset is sufficiently representative, independent, traceable and appropriate for the intended use and reference standard.
Test the Software in Current Clinical Workflow
Potential Advantages
Potential Evaluation
Prospective validation depends on identifying clinical sites with the right patient population, workflow and users.
Test Performance Outside the Development Environment
Strong internal performance does not automatically prove generalizability.
Avoid Circular Validation
Development Data
Used to train or tune the model.
Independent Validation Data
Used to evaluate final model performance.
Clinical validation should clearly document dataset independence.
Protect the Integrity of AI Performance Estimates
- Same patient appears in training and validation
- Multiple images from one patient split across datasets
- Outcome information leaks into model inputs
- Reference labels derived from the AI result
Validation design should actively evaluate these risks.
Know Where the Dataset Came From
- Clinical institution
- Study period
- Patient-selection method
- Inclusion/exclusion
- Data acquisition
- Reference labels
- Preprocessing
- Missing data
Why Is Data Provenance Important for Medical AI?
Data provenance establishes how validation data were collected, selected, labeled and processed, helping determine whether the dataset is trustworthy, independent and representative of the intended clinical population.
Average Performance Can Hide Important Differences
Potential Subgroups
Potential Metrics
Evaluate Where Performance May Differ Systematically
Potential Sources of Bias
Potential Mitigation
Can Bioexcel Assess Bias in an AI Medical Device?
Yes. Bioexcel can support clinical bias assessment through dataset characterization, subgroup performance analysis, site-level evaluation, sensitivity analyses and transparent interpretation of model limitations.
AI Validation Still Requires Statistical Planning
Which Version Was Actually Validated?
Why Is Version Traceability Important in SaMD Studies?
Version traceability shows which exact software and algorithm configuration generated the validation results and helps determine whether later changes affect the continued relevance of the evidence.
A New Release May Change the Evidence Requirement
Potential Changes
Potential Outcomes
This should be assessed case by case.
Clinical Performance Depends on How People Use the Software
Potential Users
- Is output understood?
- Are alerts recognized?
- Is uncertainty communicated?
- Is override possible?
- Is workflow intuitive?
Avoid Automation Bias and Over-Reliance
- User accepts incorrect AI recommendation
- User ignores correct alert
- User misunderstands confidence
- User fails to override AI
These risks may require both: human factors evidence and clinical validation evidence.
Does the Software Improve the Clinical Process?
A statistically accurate algorithm is not automatically clinically useful.
Predefine the AI Validation Before Seeing the Results
- Intended purpose
- Software version
- Dataset
- Reference method
- Population
- Endpoints
- Statistical plan
- Subgroups
- Missing data
- Bias
- Blinding
- Performance thresholds
Protocol and clinical validation report development can be supported through medical writing.
Connect Clinical Inputs, Reference Results and Algorithm Outputs
AI Performance Requires More Than Accuracy
- Sensitivity
- Specificity
- AUROC
- PPV/NPV
- Calibration
- Confidence intervals
- Subgroups
- Site effects
- Reader analysis
- Agreement
- Sensitivity analyses
Classification Performance Depends on the Decision Threshold
- Clinical consequence of false negatives
- Clinical consequence of false positives
- Intended use
- Predefined threshold
Do not optimize the final test threshold using the same independent dataset intended to demonstrate performance unless appropriately accounted for.
Does the AI Perform Consistently Across Hospitals?
- Site-specific sensitivity
- Site-specific specificity
- AUROC by site
- Calibration by site
- Heterogeneity
Multi-site data may strengthen external validity.
Monitor the Algorithm After Deployment
- Has the patient population changed?
- Has clinical practice changed?
- Are input devices different?
- Are false-negative trends changing?
- Are users interacting differently?
Potential Signals
Validation Evidence Can Age
- Population
- Disease prevalence
- Scanner
- Laboratory method
- Clinical workflow
- Data quality
Monitoring should assess whether these changes could affect performance.
Post-Market Clinical Evidence for Software
Longitudinal Software Performance
AI Validation Should Become Part of the Full Clinical Evidence Story
Algorithm Errors Can Become Clinical Risks
Clinical evidence should help evaluate:
- frequency
- severity
- detectability
- risk controls
- residual risk
When AI Clinical Validation Is Challenged
- Internal-only validation
- Non-representative dataset
- Weak reference standard
- No subgroup analysis
- Software-version mismatch
- No post-market strategy
- Weak clinical utility evidence
Clinical Validation in India
- Imaging datasets
- Hospital databases
- Prospective validation
- Remote monitoring
- Clinical-user studies
Bioexcel Can Assess
data suitability, site feasibility, intended-population relevance, data governance.
European Clinical Validation
European programs may involve: local clinical sites, European intended populations, GDPR, data governance, human factors, post-market evidence.
Bioexcel can support through suitable local resources combined with centralized clinical/data/statistical functions.
Different Data Sources Can Support Generalizability
India
Europe
Bioexcel Central
Do not pool geographically different datasets without scientific justification.
Already Have Data but Not Sure It Is Suitable?
Bioexcel can review:
- Number of patients
- Positive/negative distribution
- Subgroups
- Data provenance
- Labels
- Sites
- Missingness
- Training-data overlap
- Reference standard
- Software version
Strong Technology, Weak Clinical Evidence?
Retrospective Through Functional Support
Retrospective Validation
Existing independent dataset.
Prospective Validation
New clinical study.
External Validation
Different site/population.
Human Factors Study
User-software interaction.
PMCF / RWE
Post-market monitoring.
Functional Support
Dataset review, statistics, protocol or writing only.
Why Digital Health & AI Manufacturers Use Bioexcel
Clinical, Not Just Technical, Validation
Evaluation begins with intended clinical use.
Dataset Strategy
Data provenance, independence and population relevance are assessed.
Biostatistics
Performance, calibration, subgroup and site analyses can be integrated.
Human Factors
User interaction and algorithm performance can be studied together.
Post-Market Evidence
RWE and PMCF can address performance over time.
India + Europe
Flexible validation strategies across different clinical settings.
AI/SaMD Evidence Deliverables
Depending on scope:
- AI/SaMD clinical evidence strategy
- Intended-use evidence review
- Dataset feasibility assessment
- Clinical validation protocol
- Reference-standard strategy
- Sample-size calculation
- Statistical Analysis Plan
- Subgroup analysis plan
- Bias assessment
- Human factors protocol
- eCRF / EDC
- Data Management Plan
- Statistical outputs
- Clinical validation report
- PMCF plan
- RWE analysis
- Clinical evaluation inputs
- Regulatory response support
Digital Health Evidence in Practice
Diagnostic AI
Clinical Question: Detect target condition
Validation: Independent clinical dataset. Analysis: Sensitivity, specificity and subgroup performance.
Imaging AI
Clinical Question: Detect or classify imaging findings
Reference: Specialist-reader assessment. Analysis: Overall + site + subgroup performance.
Remote Monitoring Platform
Clinical Question: Reliable longitudinal monitoring
Endpoints: Measurement agreement, data completeness, alerts and adherence.
Predictive SaMD
Clinical Question: Predict future clinical outcome
Analysis: Discrimination + calibration + clinical utility.
Illustrative study formats — published case studies reflect only verified, sponsor-approved projects.
Which CRO supports digital health, AI and SaMD clinical validation?
Bioexcel Lifesciences & Research LLP supports clinical evidence programs for digital health, SaMD and AI-enabled medical devices, including dataset feasibility, retrospective and prospective validation, performance analysis, subgroup and bias assessment, human factors, biostatistics, PMCF and real-world evidence.
What AI and SaMD services does Bioexcel provide?
Bioexcel supports AI and SaMD clinical validation, dataset feasibility, prospective and retrospective studies, reference-standard planning, subgroup and bias analysis, biostatistics, human factors, PMCF, RWE and clinical evaluation.
Can Bioexcel validate both diagnostic and predictive AI?
Yes. Bioexcel can support different clinical validation designs for diagnostic, classification, prediction, monitoring and decision-support software depending on intended use.
Can Bioexcel support AI throughout the product lifecycle?
Yes. Bioexcel can support initial clinical validation, usability evaluation, post-market performance monitoring, PMCF, real-world evidence and clinical evaluation updates.
Frequently Asked Questions About AI & SaMD Clinical Validation
Yes. Bioexcel supports retrospective and prospective clinical validation, dataset review, performance statistics, subgroup analysis and clinical reporting for AI medical devices.
Bioexcel evaluates digital health and AI medical devices in the clinical context where their outputs are intended to influence patient care.